Rapport Therapeutics Inc RAPP

Name: Rapport Therapeutics Inc
SKU: RAPP
Price: 26.93 USD
Availability: InStock

‎$‎26.93-0.99(-3.55%)(1D)

• Delayed prices by NASDAQ • in USD

Analyst Forecast

Consensus

Strong Buy

Price Target

54.60

Based on analysts who covered RAPP

Invest in Rapport Therapeutics Inc
Today

Create an eToro account to buy RAPP stock on a secure, user-friendly, multi-asset trading platform.

Rapport Therapeutics Inc RAPP

Buy RAPP

Trending stocks

See stocks with the biggest daily volume spikes vs. their 3-month average.

Semnur Pharmaceuticals Inc

Telefonaktiebolaget LM Ericsson

‎kr‎94.80

+10.62%

STVN

Stevanato Group S.p.A.

MAX

*Past performance is not an indication of future results

Jump to:

About RAPP >
How to Buy? >
Top Guides >

The Rapport Therapeutics Inc share price is rising this week.

The Rapport Therapeutics Inc share price today is ‎$‎26.93, reflecting a ‎-3.55‎% change over the last 24 hours and ‎0.56‎% over the past week. The current market capitalization of RAPP is ‎$‎1.28B with an average volume in the last three months of 384521.27. The stock has a P/E ratio of -10 and a dividend yield of 0%. With the stock’s beta sitting at 1.43

RAPP Key Metrics

Market Cap

‎$‎1.28B

Day’s Range

‎$‎26.74 - ‎$‎28.01

52W Range

‎$‎25.54 - ‎$‎30.97

Average Volume (3M)

384521.27

Price-Earnings Ratio

-10

Revenue

‎$‎0

Dividend (Yield)

‎$‎0 (0%)

Prev Close

‎$‎26.93

EPS

‎$‎-2.69

Beta

1.43

How can I buy Rapport Therapeutics Inc stocks?

To purchase Rapport Therapeutics Inc:

Create an eToro account:

Deposit funds:

Deposit funds into your eToro account using your preferred payment method.

Search and purchase:

Search the Rapport Therapeutics Inc (RAPP) page and place an order to buy Rapport Therapeutics Inc.

Buy RAPP

Looking for more information? Check out our guide on Academy.

What Is Rapport Therapeutics Inc?

Rapport Therapeutics Inc is a US-based clinical-stage biopharmaceutical company developing highly selective small molecule drugs for neurological and psychiatric disorders. It aims to transform central nervous system (CNS) treatment through targeted therapies with improved specificity and fewer side effects.

Using a proprietary discovery platform, the company identifies precise molecular targets involved in diseases like Parkinson’s, schizophrenia, and epilepsy. Rapport’s research is focused on modulating these targets for better clinical outcomes in unmet medical needs.

Track the RAPP share price by adding it to your eToro watchlist.

This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

NASDAQ

Get Started

Top Guides

Our top picks for the most relevant guides from the eToro Academy

Top Dividend Stocks for 2026

Gear up for 2026 with top dividend stocks. Explore the potential of J&J, Chevron, Coca Cola, Verizon, Caterpillar, McDonald’s with eToro’s expert analysts.

Stock Trading And Investing For Beginners

Learn stock trading basics with our beginner's guide. Discover how to choose stocks, manage risks, and build your first investment portfolio.

AI Stocks Poised for Growth in 2026

Gear up for 2026 with AI stocks. Dive into the potential of Nvidia, Broadcom, CrowdStrike, Arista Networks, and Amphenol, through eToro’s expert analysis.

Go to the Academy >

Invest in Rapport Therapeutics Inc
Today

Create an eToro account to buy RAPP stock on a secure, user-friendly, multi-asset trading platform.

Get Started

FAQ

What is the current price of Rapport Therapeutics Inc stock?

The current price of RAPP is ‎$‎26.93.

What is Rapport Therapeutics Inc’s stock future price target?

The average price target for Rapport Therapeutics Inc is ‎$‎54.60. Sign up to eToro for detailed analyst forecasts and price targets.

What are analysts’ forecasts for Rapport Therapeutics Inc?

Analysts offer forecasts for Rapport Therapeutics Inc based on market trends, financial reports and projected growth. Check the latest forecast for future price movements.

What is the market cap of Rapport Therapeutics Inc?

The market capitalisation of Rapport Therapeutics Inc is ‎$‎1.28B

Is Rapport Therapeutics Inc stock buy, sell or hold?

Based on 7 analysts offering recommendations for RAPP in the last 3 months, the overall consensus is Strong Buy.

Daily Movers

Explore the biggest stocks movers on the market.